Audio Summary

doi : 10.1016/S0735-1097(25)06989-X

Volume 86, Issue 5, 5 August 2025, Page e47

Buy The Package and View The Article Online

Contents

doi : 10.1016/S0735-1097(25)06991-8

Buy The Package and View The Article Online

Heart Failure in Practice: What and How

doi : 10.1016/j.jacc.2025.06.028

Buy The Package and View The Article Online

Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial

doi : 10.1016/j.jacc.2025.05.033

Buy The Package and View The Article Online

Combining SGLT2i and MRAs in Heart Failure: Playing the Long Game

doi : 10.1016/j.jacc.2025.06.029

Buy The Package and View The Article Online

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

doi : 10.1016/j.jacc.2025.05.040

Buy The Package and View The Article Online

Mapping the Journeys to and From Improved Ejection Fraction

doi : 10.1016/j.jacc.2025.06.027

Buy The Package and View The Article Online

Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases

doi : 10.1016/j.jacc.2025.06.012

Buy The Package and View The Article Online

Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure

doi : 10.1016/j.jacc.2025.05.061

Buy The Package and View The Article Online

Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial

doi : 10.1016/j.jacc.2025.05.038

Buy The Package and View The Article Online

Sex Differences in the Genetic Causes of Dilated Cardiomyopathy

doi : 10.1016/j.jacc.2025.04.068

Buy The Package and View The Article Online

Atrial Fibrillation and Systemic Embolic Events in Patients With LMNA Cardiomyopathy

doi : 10.1016/j.jacc.2025.05.039

Buy The Package and View The Article Online